Cryptocurrency
Prediction markets seen hitting $1T by 2030
Prediction market volumes could reach $1 trillion by 2030, according to analysts at Bernstein, as institutional adoption expands beyond sports betting.
Mahathir Bayena
Crypto JournalistCrypto journalist for Grafa, with nearly 10 years of experience covering blockchain, Web3, and NFT gaming trends. MBA & Economics grad.
Contact
Contact editorial teamArticles by Mahathir Bayena
Cryptocurrency
Deutsche Börse takes $200M stake in Kraken
Deutsche Börse has invested $200 million to acquire a 1.5% stake in crypto exchange Kraken, marking a major step by a traditional exchange into digital assets.
Health
Telix launches US$550M convertible note refinancing
Telix Pharmaceuticals (ASX:TLX) announced the launch of a US$550 million offering of senior unsecured convertible notes due 2031.
-640x359.webp&w=3840&q=75)
Health
PainChek secures major US deal with Sabra REIT
PainChek (ASX:PCK) announced a master services agreement with Sabra Health Care REIT (NASDAQ:SBRA).
Technology
Simble Solutions bolsters ladership and green tech strategy
Simble Solutions (ASX:SIS) announced a series of administrative and leadership updates following its latest general meeting.
Black Canyon commences major drilling at Wandanya Project
Black Canyon (ASX:BCA) commenced a pivotal resource definition and expansion drilling programme at its Wandanya Project.
Health
Clarity signs major manufacturing deal for cancer imaging
Clarity Pharmaceuticals (ASX:CU6) has announced a landmark commercial manufacturing agreement with Nucleus RadioPharma.
Nexus Minerals starts major drilling at Wallbrook Project
Nexus Minerals (ASX:NXM) starts a major 22,000m drilling programme at the Wallbrook Gold Project to drive resource growth
Technology
Tyler Technologies closes $212.5M acquisition of For The Record
Tyler Technologies (NYSE:TYL) announced on Tuesday, April 14, 2026, that it has finalized the acquisition of For The Record, a prominent innovator in digital court-recording and legal transcription.
FDA grants full approval to FILSPARI for FSGS, securing new royalty stream for Ligand
Ligand Pharmaceuticals (NASDAQ:LGND) announced on Tuesday, April 14, 2026, that its partner, Travere Therapeutics, has received full U.S. Food and Drug Administration (FDA) approval for FILSPARI (sparsentan).